PETALING JAYA: Brighter days await Optimax Holdings Bhd
, underpinned by the growth in the number of refractive surgeries and the launch of new satellite clinics and ambulatory care centres (ACC).
Maybank Investment Bank Research (Maybank IB Research) says the eye-care specialist remains optimistic about sustained surgery-volume growth due to high operating theatre utilisation, introduction of new technology, and a high-margin surgery mix.
In the financial year ended Dec 31, 2023 (FY23), Optimax’s refractive surgery volume grew 5% year-on-year (y-o-y), making up 37% of total revenue, with the introduction of the Zeiss Smile Pro eye procedure at the end of the third quarter of 2023. This offset the slower cataract-surgery volume which declined 2% y-o-y in FY23.
“This is positive as the refractive segment gives higher revenue per surgery and offers greater volume-growth capacity given its tech-sophistication and short surgery time of less than 10 seconds for refractive laser treatment.
...